Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)
- Author
- PRAKASH, S. R1 ; CABLE, K. M; CORREA, I. D1 ; FELLOWS, I; MONTGOMERY, S; NEWMAN, J. J; WATERHOUSE, I; WELLS, G. N; SUTHERLAND, D. R
[1] Glaxo Research Institute, Research Triangle Park NC 27709, United States - Source
Journal of labelled compounds & radiopharmaceuticals. 1995, Vol 36, Num 10, pp 993-1007 ; ref : 12 ref
- ISSN
- 0362-4803
- Scientific domain
- Biochemistry, molecular biology, biophysics; Organic chemistry; Pharmacology drugs
- Publisher
- Wiley, Chichester
/
Wiley, New York, NY
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Alosétron Antagoniste Carbone Isotope Composé aromatique Composé marqué Composé tricyclique Cycle 5 chaînons Cyclisation Deutérium Hydrogène Isotope Hétérocycle azote Lactame Lurosétron Marquage radioisotopique Récepteur sérotoninergique 5-HT3 Synthèse chimique Carbone 14 Imidazole-4-méthanol(5-méthyl) Phénylhydrazine(2-fluoro) Phénylhydrazine Pipéridine-2,4-dione Pyrido[4,3-b]indol-1-one dérivé Pyridoindole
- Keyword (en)
- Antagonist Carbon Isotopes Aromatic compound Labelled compound Tricyclic compound Five membered ring Cyclization Deuterium Hydrogen Isotopes Nitrogen heterocycle Lactam Radiolabelling 5-HT3 receptor Chemical synthesis
- Keyword (es)
- Antagonista Carbono Isótopo Compuesto aromático Compuesto marcado Compuesto tricíclico Ciclo 5 eslabones Ciclización Deuterio Hidrógeno Isótopo Heterociclo nitrógeno Lactamo Marcación radioisotópica Receptor serotoninérgico 5-HT3 Síntesis química
- Classification
- Pascal
- 001 Exact sciences and technology / 001C Chemistry / 001C03 Organic chemistry / 001C03C Preparations and properties / 001C03C06 Heterocyclic compounds / 001C03C06C Heterocyclic compounds with several n hetero atoms in the same ring, in separated rings or in fused rings
- Discipline
- Organic chemistry
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3669670
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/jlcr.2580361011 
https://dx.doi.org/10.1002/jlcr.2580361011
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:9:\"\u0000*\u0000jtitle\";s:52:\"Journal of labelled compounds & radiopharmaceuticals\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. labelled compd. radiopharm\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"993\";s:8:\"\u0000*\u0000epage\";s:4:\"1007\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0362-4803\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PRAKASH\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:11:\"CABLE, K. M\";i:1;s:12:\"CORREA, I. D\";i:2;s:10:\"FELLOWS, I\";i:3;s:13:\"MONTGOMERY, S\";i:4;s:12:\"NEWMAN, J. J\";i:5;s:13:\"WATERHOUSE, I\";i:6;s:11:\"WELLS, G. N\";i:7;s:16:\"SUTHERLAND, D. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:8:\"\u0000*\u0000place\";s:10:\"Chichester\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:9:\"\u0000*\u0000jtitle\";s:52:\"Journal of labelled compounds & radiopharmaceuticals\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. labelled compd. radiopharm\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"993\";s:8:\"\u0000*\u0000epage\";s:4:\"1007\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0362-4803\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PRAKASH\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:11:\"CABLE, K. M\";i:1;s:12:\"CORREA, I. D\";i:2;s:10:\"FELLOWS, I\";i:3;s:13:\"MONTGOMERY, S\";i:4;s:12:\"NEWMAN, J. J\";i:5;s:13:\"WATERHOUSE, I\";i:6;s:11:\"WELLS, G. N\";i:7;s:16:\"SUTHERLAND, D. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:8:\"\u0000*\u0000place\";s:10:\"Chichester\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:9:\"\u0000*\u0000jtitle\";s:52:\"Journal of labelled compounds & radiopharmaceuticals\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. labelled compd. radiopharm\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"993\";s:8:\"\u0000*\u0000epage\";s:4:\"1007\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0362-4803\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PRAKASH\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:11:\"CABLE, K. M\";i:1;s:12:\"CORREA, I. D\";i:2;s:10:\"FELLOWS, I\";i:3;s:13:\"MONTGOMERY, S\";i:4;s:12:\"NEWMAN, J. J\";i:5;s:13:\"WATERHOUSE, I\";i:6;s:11:\"WELLS, G. N\";i:7;s:16:\"SUTHERLAND, D. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:8:\"\u0000*\u0000place\";s:10:\"Chichester\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:9:\"\u0000*\u0000jtitle\";s:52:\"Journal of labelled compounds & radiopharmaceuticals\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. labelled compd. radiopharm\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"993\";s:8:\"\u0000*\u0000epage\";s:4:\"1007\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0362-4803\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PRAKASH\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:11:\"CABLE, K. M\";i:1;s:12:\"CORREA, I. D\";i:2;s:10:\"FELLOWS, I\";i:3;s:13:\"MONTGOMERY, S\";i:4;s:12:\"NEWMAN, J. J\";i:5;s:13:\"WATERHOUSE, I\";i:6;s:11:\"WELLS, G. N\";i:7;s:16:\"SUTHERLAND, D. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:8:\"\u0000*\u0000place\";s:10:\"Chichester\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1002\/jlcr.2580361011\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:9:\"\u0000*\u0000jtitle\";s:52:\"Journal of labelled compounds & radiopharmaceuticals\";s:9:\"\u0000*\u0000stitle\";s:29:\"J. labelled compd. radiopharm\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"36\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"993\";s:8:\"\u0000*\u0000epage\";s:4:\"1007\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0362-4803\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"PRAKASH\";s:10:\"\u0000*\u0000aufirst\";s:4:\"S. R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:11:\"CABLE, K. M\";i:1;s:12:\"CORREA, I. D\";i:2;s:10:\"FELLOWS, I\";i:3;s:13:\"MONTGOMERY, S\";i:4;s:12:\"NEWMAN, J. J\";i:5;s:13:\"WATERHOUSE, I\";i:6;s:11:\"WELLS, G. N\";i:7;s:16:\"SUTHERLAND, D. R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:80:\"Synthesis of isotopically labelled pyridoindolone 5-HT3 receptor antagonists (1)\";s:8:\"\u0000*\u0000place\";s:10:\"Chichester\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
